ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 157 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 3.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $24,518,000 | +33.3% | 1,300,000 | -16.8% | 0.98% | +46.9% |
| Q2 2019 | $18,388,000 | -13.6% | 1,562,300 | +0.1% | 0.66% | -19.0% |
| Q1 2019 | $21,294,000 | +40.8% | 1,560,000 | +5.8% | 0.82% | +15.0% |
| Q4 2018 | $15,119,000 | -44.4% | 1,475,000 | -9.6% | 0.71% | -27.4% |
| Q3 2018 | $27,181,000 | +9.9% | 1,632,500 | +4.3% | 0.98% | +3.5% |
| Q2 2018 | $24,727,000 | +27.3% | 1,565,000 | +2.3% | 0.95% | +14.7% |
| Q1 2018 | $19,428,000 | +60.8% | 1,529,800 | +45.0% | 0.83% | +51.3% |
| Q4 2017 | $12,080,000 | +12.7% | 1,055,000 | +20.6% | 0.55% | +10.7% |
| Q3 2017 | $10,719,000 | +414.3% | 875,000 | +380.8% | 0.50% | +371.4% |
| Q2 2017 | $2,084,000 | -45.0% | 182,000 | 0.0% | 0.10% | -51.8% |
| Q1 2017 | $3,786,000 | 0.0% | 182,000 | 0.0% | 0.22% | -13.8% |
| Q4 2016 | $3,786,000 | -36.5% | 182,000 | 0.0% | 0.25% | -32.4% |
| Q3 2016 | $5,964,000 | +32.3% | 182,000 | +0.8% | 0.37% | +12.0% |
| Q2 2016 | $4,507,000 | +88.7% | 180,500 | +85.1% | 0.33% | +67.0% |
| Q1 2016 | $2,388,000 | – | 97,500 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |